News

MUSC team finds a new, more specific biomarker for a liver cancer type. Currently, no specific diagnostic tools of this type exist for this disease.

With SCTR pilot funding, a bioengineer and vascular surgeon collaborate on potentially heart-saving science.

Will remote trials overcome the barriers that make it difficult for underserved populations to participate in clinical trials? A Hollings researcher weighs in.

A Hollings researcher wants to ID risk biomarkers to enable doctors to stop a serious side effect of stem cell transplant before it happens.

An MUSC Hollings Cancer Center doctor is leading a national trial to test whether drugs used after large B-cell lymphoma returns could instead prevent relapse.

Return to use of opioids after stopping can heighten overdose risk. The McGinty Lab has found a way to reduce return to use in a preclinical model.

As Michael J. Fox shares life story in documentary, including Parkinson’s struggle, an MUSC expert explains the disease, its treatments and hopes for future.

MUSC study identifies a second target for treating depression with transcranial magnetic stimulation.

New treatment approach for babies born dependent on opioids gets them healthy and home faster.

On May 11, Dr. Alex Spiotta will be joined by some of the best and brightest minds in the world of stroke and aneurysm treatment for the first STAR Symposium.